Eduardo has over 15 years of business development and finance experience. Prior to joining RayzeBio, he served as Executive Director of M&A at Bristol Myers Squibb, where he executed multiple strategic transactions, including the acquisition of RayzeBio. Prior to BMS, Eduardo spent over a decade at GE executing various BD transactions, including in the Pharma Diagnostics and Radiopharma sectors.
Eduardo is a graduate of the University of Brasília (Brazil) and holds a Master of Business Administration from the University of Chicago’s Booth School of Business.
